Core Viewpoint - Medline is preparing for an IPO on Nasdaq under the ticker "MDLN.US," which is expected to be the largest IPO in the U.S. stock market in 2025 [1] Group 1: IPO Details - Medline plans to issue 179 million shares with a pricing range of $26 to $30 per share, aiming to raise up to $5.37 billion [1] - The target valuation for Medline is set at $55.3 billion [1] Group 2: Company Background - Founded in 1910, Medline is the largest manufacturer and distributor of medical supplies globally, with products including gloves and surgical instruments [1] - The company was privatized in 2021 after being acquired by Blackstone, Carlyle, and Hellman & Friedman for $34 billion [1] Group 3: Financial Performance - For the first nine months of 2025, Medline reported a net profit of $977 million and revenue of $20.6 billion, both showing year-over-year growth [1] - The company has warned that equivalent tariffs will reduce pre-tax net profit by $325 to $375 million in 2025, and by $150 to $200 million in 2026 [1] Group 4: Market Expectations - The market anticipates that Medline will officially begin trading on December 17 [1]
快讯 | 医疗巨头Medline冲刺2025年美股最大IPO估值达553亿美元